This study aims to assess the utility of an ECCO2R device called Prismalung in reducing ventilator induced lung injury in intubated patients who have a driving pressure (ΔP) > 14 and/or Plateau pressure >/= 25, elevated respiratory rate with hypercarbia and acidaemia.